Michael Klowden insider trades
Open-market stock purchases and sales by Michael Klowden, Director at NKGen Biotech, Inc, from SEC Form 4 filings since Feb 12, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- NKGN NKGen Biotech, Inc: other filings, last Dec 6, 2024